Insulinoma Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Global Insulinoma Treatment Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031 growing at a CAGR of YY% during the forecast period 2024-2031. Insulinomas are rare pancreatic endocrine tumors that can be benign or malignant. Only 10% of insulinomas are malignant. The main symptom is hypoglycemia, i.e., a decrease in blood sugar levels due to the oversecretion of insulin. Most insulinomas are non-cancerous. Hence, the drugs used are to decrease the amount of insulin secreted by islet cells in the pancreas.